Ebitda Изменить Дата
AbbVie USD 6.91B 3.22B 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amarin USD 12.54M 28.57M 2025-06
AstraZeneca USD 7.46B 2.3B 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
DBV Technologies USD -61.2M 15.3M 2026-09
GlaxoSmithKline GBP 3.51B 734M 2026-06
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09